Literature DB >> 33400004

Bone microarchitectural alterations in boys with Duchenne muscular dystrophy on long-term glucocorticoid treatment.

Joanna Yuet-Ling Tung1,2, Tsz-Ping Lam3,4, Sophelia Hoi-Shan Chan5.   

Abstract

INTRODUCTION: Osteoporosis is a major health issue in boys with Duchenne muscular dystrophy (DMD). Data on the specific bone deficits and microarchitectural alterations in children with DMD were limited. This study aimed to assess the bone microarchitectural alterations in boys with DMD on long-term glucocorticoid using high-resolution peripheral quantitative computed tomography (HR-pQCT).
MATERIALS AND METHODS: This was a cross-sectional, case-control study. Boys with DMD older than 5 years with no prior history of symptomatic fracture and had been on long-term glucocorticoid treatment were recruited from a single tertiary centre. For each participant, three gender- and age-matched controls were selected randomly from an existing HR-pQCT database of healthy individuals.
RESULTS: Nine boys with DMD at a median age of 9.3 years were included. Three were found to have asymptomatic vertebral compression fracture. The HR-pQCT findings of these nine boys were compared with 27 healthy controls. Trabecular microstructure indices at the distal radius were significantly lower but the cortical vBMD was significantly higher in the DMD boys when compared with healthy controls.
CONCLUSION: Lower microarchitectural measurement of trabecular bones, but higher cortical vBMD, was observed in DMD boys on long-term oral glucocorticoid. The results from this study provide preliminary, yet important insights into the bone microarchitecture of this group of patients.

Entities:  

Keywords:  Bone microarchitecture index; Duchenne muscular dystrophy; Glucocorticoid; HR-pQCT; Osteoporosis

Year:  2021        PMID: 33400004     DOI: 10.1007/s00774-020-01196-w

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  14 in total

1.  HR-pQCT: a non-invasive 'biopsy' to assess bone structure and strength.

Authors:  M G Digby; N J Bishop; M A Paggiosi; A C Offiah
Journal:  Arch Dis Child Educ Pract Ed       Date:  2016-04-27       Impact factor: 1.309

2.  Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study.

Authors:  Babette S Zemel; Heidi J Kalkwarf; Vicente Gilsanz; Joan M Lappe; Sharon Oberfield; John A Shepherd; Margaret M Frederick; Xiangke Huang; Ming Lu; Soroosh Mahboubi; Thomas Hangartner; Karen K Winer
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

Review 3.  Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.

Authors:  Jennifer M Bell; Michael D Shields; Janet Watters; Alistair Hamilton; Timothy Beringer; Mark Elliott; Rosaline Quinlivan; Sandya Tirupathi; Bronagh Blackwood
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

4.  Trabecular and cortical microstructure and fragility of the distal radius in women.

Authors:  Yohann Bala; Quang Minh Bui; Xiao-Fang Wang; Sandra Iuliano; Qingju Wang; Ali Ghasem-Zadeh; Tamara D Rozental; Mary L Bouxsein; Roger M D Zebaze; Ego Seeman
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

Review 5.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

6.  Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up.

Authors:  Sylvie Houde; Michèle Filiatrault; Anne Fournier; Julie Dubé; Sylvie D'Arcy; Denis Bérubé; Yves Brousseau; Guy Lapierre; Michel Vanasse
Journal:  Pediatr Neurol       Date:  2008-03       Impact factor: 3.372

7.  Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy.

Authors:  Cuixia Tian; Brenda L Wong; Lindsey Hornung; Jane C Khoury; Lauren Miller; Jean Bange; Irina Rybalsky; Meilan M Rutter
Journal:  Neuromuscul Disord       Date:  2016-08-22       Impact factor: 4.296

8.  Fat Embolism Syndrome following minor trauma in Duchenne muscular dystrophy.

Authors:  Laura C McAdam; Anjali Rastogi; Kathleen Macleod; W Douglas Biggar
Journal:  Neuromuscul Disord       Date:  2012-08-21       Impact factor: 4.296

Review 9.  Optimizing Bone Health in Duchenne Muscular Dystrophy.

Authors:  Jason L Buckner; Sasigarn A Bowden; John D Mahan
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

10.  Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions.

Authors:  Nicola J Crabtree; Asma Arabi; Laura K Bachrach; Mary Fewtrell; Ghada El-Hajj Fuleihan; Heidi H Kecskemethy; Maciej Jaworski; Catherine M Gordon
Journal:  J Clin Densitom       Date:  2014-03-29       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.